- They submitted a manuscript to a peer-review journal earlier this week.
- They have collaborations being set up to use Lenz in other areas, not just CAR-T, Covid, etc.
-Feedback from FDA is good, no real update on EUA. Couldn't give an exact time frame.
- Europe Regulatory submission going well
-He mentioned that they are using partnerships to register in other countries. He named India, Korea, and I forget where else. This could be huge! Contracts!
- He mentioned "LARGE company looking for small company with great Intellectual property". And he emphasized "LARGE". That to me means either huge partnership deal or BUYOUT.
-He talked a bit about ACTIV-5 being almost completely enrolled.
-Mentioned possibly increasing the size of ACTIV-5 so it can be used for BLA submission.
Those were my takeaways. Some of the other stuff he talked about was stuff we already know.
Let me know what I may have missed.
****These were notes taken by someone on another board.